RhumbLine Advisers’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
RhumbLine Advisers's ORGO Position: Q3 2026 in Review
RhumbLine Advisers reduced its Organogenesis Holdings (ORGO) stake by 2% in Q3 2026, selling an estimated $3.37K and leaving 83,945 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #3478.
RhumbLine Advisers first reported a position in ORGO in Q2 2020 and has held it in 26 quarters since. The position peaked at $1.96M in Q2 2021. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- RhumbLine Advisers held 83,945 shares of Organogenesis Holdings worth $115K as of Q3 2026.
- RhumbLine Advisers sold 1,715 Organogenesis Holdings shares in Q3 2026, an estimated $3.37K.
- Organogenesis Holdings made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3478 holding.
- RhumbLine Advisers first reported a position in Organogenesis Holdings in Q2 2020 and has held it in 26 quarters since.
- RhumbLine Advisers's Organogenesis Holdings position peaked at $1.96M in Q2 2021.
- 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.